Drug Profile
ICL 749B
Alternative Names: Deferoxamine depot; Desferrioxamine depotLatest Information Update: 23 Mar 2000
Price :
$50
*
At a glance
- Originator Novartis
- Class
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Iron overload